{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:01:48Z","timestamp":1784091708271,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10147-014-0754-7","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T01:20:41Z","timestamp":1413249641000},"page":"463-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?"],"prefix":"10.1007","volume":"20","author":[{"given":"Hee Yong","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Joo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hwa","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ran","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Beom","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Joo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Seol","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Seong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"issue":"3","key":"754_CR1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/EP:17:3:235","volume":"17","author":"R Sargent","year":"2006","unstructured":"Sargent R, LiVolsi V, Murphy J et al (2006) BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 17(3):235\u2013241","journal-title":"Endocr Pathol"},{"issue":"2","key":"754_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/path.1511","volume":"202","author":"V Trovisco","year":"2004","unstructured":"Trovisco V, Vieira de Castro I, Soares P et al (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202(2):247\u2013251","journal-title":"J Pathol"},{"issue":"5","key":"754_CR3","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2003-031425","volume":"89","author":"E Puxeddu","year":"2004","unstructured":"Puxeddu E, Moretti S, Elisei R et al (2004) BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89(5):2414\u20132420","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"754_CR4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.2004.02089.x","volume":"61","author":"L Fugazzola","year":"2004","unstructured":"Fugazzola L, Mannavola D, Cirello V et al (2004) BRAF mutations in an Italian cohort of thyroid cancers. Clin Endocrinol 61(2):239\u2013243","journal-title":"Clin Endocrinol"},{"issue":"1","key":"754_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","volume":"13","author":"YE Nikiforov","year":"2002","unstructured":"Nikiforov YE (2002) RET\/PTC rearrangement in thyroid tumors. Endocr Pathol 13(1):3\u201316","journal-title":"Endocr Pathol"},{"issue":"2","key":"754_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/thy.2008.0144","volume":"19","author":"SK Kim","year":"2009","unstructured":"Kim SK, Song KH, Lim SD et al (2009) Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19(2):137\u2013141","journal-title":"Thyroid"},{"issue":"4","key":"754_CR7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI200522758","volume":"115","author":"RM Melillo","year":"2005","unstructured":"Melillo RM, Castellone MD, Guarino V et al (2005) The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115(4):1068\u20131081","journal-title":"J Clin Invest"},{"issue":"12","key":"754_CR8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1089\/thy.1999.9.1237","volume":"9","author":"JH Chung","year":"1999","unstructured":"Chung JH, Hahm JR, Min YK et al (1999) Detection of RET\/PTC oncogene rearrangements in Korean papillary thyroid carcinomas. Thyroid 9(12):1237\u20131243","journal-title":"Thyroid"},{"issue":"3","key":"754_CR9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2265.1998.00515.x","volume":"49","author":"KY Park","year":"1998","unstructured":"Park KY, Koh JM, Kim YI et al (1998) Prevalences of Gs alpha, ras, p53 mutations and ret\/PTC rearrangement in differentiated thyroid tumours in a Korean population. Clin Endocrinol 49(3):317\u2013323","journal-title":"Clin Endocrinol"},{"issue":"3","key":"754_CR10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2265.2006.02605.x","volume":"65","author":"TY Kim","year":"2006","unstructured":"Kim TY, Kim WB, Rhee YS et al (2006) The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma. Clin Endocrinol 65(3):364\u2013368","journal-title":"Clin Endocrinol"},{"issue":"5","key":"754_CR11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2265.2006.02646.x","volume":"65","author":"KW Chung","year":"2006","unstructured":"Chung KW, Yang SK, Lee GK et al (2006) Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol 65(5):660\u2013666","journal-title":"Clin Endocrinol"},{"issue":"5","key":"754_CR12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3349\/ymj.2004.45.5.818","volume":"45","author":"KH Kim","year":"2004","unstructured":"Kim KH, Kang DW, Kim SH et al (2004) Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45(5):818\u2013821","journal-title":"Yonsei Med J"},{"issue":"4","key":"754_CR13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2004.02085.x","volume":"61","author":"AP Weetman","year":"2004","unstructured":"Weetman AP (2004) Cellular immune responses in autoimmune thyroid disease. Clin Endocrinol 61(4):405\u2013413","journal-title":"Clin Endocrinol"},{"issue":"1","key":"754_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","volume":"321","author":"V Guarino","year":"2010","unstructured":"Guarino V, Castellone MD, Avilla E et al (2010) Thyroid cancer and inflammation. Mol Cell Endocrinol 321(1):94\u2013102","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"754_CR15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1440-1827.2005.01866.x","volume":"55","author":"KH Kim","year":"2005","unstructured":"Kim KH, Suh KS, Kang DW et al (2005) Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto\u2019s thyroiditis. Pathol Int 55(9):540\u2013545","journal-title":"Pathol Int"},{"issue":"11","key":"754_CR16","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jc.2011-1469","volume":"96","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov YE, Ohori NP, Hodak SP et al (2011) Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96(11):3390\u20133397","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"754_CR17","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","volume":"88","author":"MN Nikiforova","year":"2003","unstructured":"Nikiforova MN, Kimura ET, Gandhi M et al (2003) BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88(11):5399\u20135404","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"754_CR18","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1210\/jc.2003-032221","volume":"89","author":"G Salvatore","year":"2004","unstructured":"Salvatore G, Giannini R, Faviana P et al (2004) Analysis of BRAF point mutation and RET\/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 89(10):5175\u20135180","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"754_CR19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/01.pap.0000213044.23823.d3","volume":"13","author":"MT Tetzlaff","year":"2006","unstructured":"Tetzlaff MT, LiVolsi V, Baloch ZW (2006) Assessing the utility of a mutational assay for B-RAF as an adjunct to conventional fine needle aspiration of the thyroid gland. Adv Anat Pathol 13(5):228\u2013237","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"754_CR20","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1210\/jc.2003-032050","volume":"89","author":"M Xing","year":"2004","unstructured":"Xing M, Tufano RP, Tufaro AP et al (2004) Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89(6):2867\u20132872","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"754_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/hupa.2001.21138","volume":"32","author":"M Pasquale Di","year":"2001","unstructured":"Di Pasquale M, Rothstein JL, Palazzo JP (2001) Pathologic features of Hashimoto\u2019s-associated papillary thyroid carcinomas. Hum Pathol 32(1):24\u201330","journal-title":"Hum Pathol"},{"issue":"3","key":"754_CR22","first-page":"365","volume":"55","author":"A Pisanu","year":"2003","unstructured":"Pisanu A, Piu S, Cois A et al (2003) Coexisting Hashimoto\u2019s thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy. Chir Ital 55(3):365\u2013372","journal-title":"Chir Ital"},{"issue":"8","key":"754_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1288\/00005537-199308000-00003","volume":"103","author":"AP Sclafani","year":"1993","unstructured":"Sclafani AP, Valdes M, Cho H (1993) Hashimoto\u2019s thyroiditis and carcinoma of the thyroid: optimal management. Laryngoscope 103(8):845\u2013849","journal-title":"Laryngoscope"},{"issue":"9","key":"754_CR24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1001\/archsurg.1989.01410090055012","volume":"124","author":"BL Eisenberg","year":"1989","unstructured":"Eisenberg BL, Hensley SD (1989) Thyroid cancer with coexistent Hashimoto\u2019s thyroiditis. Clinical assessment and management. Arch Surg 124(9):1045\u20131047","journal-title":"Arch Surg"},{"issue":"8","key":"754_CR25","first-page":"442","volume":"53","author":"RA Ott","year":"1987","unstructured":"Ott RA, McCall AR, McHenry C et al (1987) The incidence of thyroid carcinoma in Hashimoto\u2019s thyroiditis. Am Surg 53(8):442\u2013445","journal-title":"Am Surg"},{"issue":"3","key":"754_CR26","first-page":"205","volume":"70","author":"K Segal","year":"1985","unstructured":"Segal K, Ben-Bassat M, Avraham A et al (1985) Hashimoto\u2019s thyroiditis and carcinoma of the thyroid gland. Int Surg 70(3):205\u2013209","journal-title":"Int Surg"},{"key":"754_CR27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/0194599812472426","volume":"148","author":"Y Lun","year":"2013","unstructured":"Lun Y, Wu X, Xia Q et al (2013) Hashimoto\u2019s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 148:396\u2013402","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"754_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1245\/s10434-012-2611-0","volume":"20","author":"GM Howell","year":"2013","unstructured":"Howell GM, Nikiforova MN, Carty SE et al (2013) BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. Ann Surg Oncol 20(1):47\u201352","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"754_CR29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/SLA.0b013e318148563d","volume":"246","author":"E Kebebew","year":"2007","unstructured":"Kebebew E, Weng J, Bauer J et al (2007) The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg 246(3):466\u2013470 (discussion 70\u20131)","journal-title":"Ann Surg"},{"issue":"11","key":"754_CR30","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2007-1179","volume":"92","author":"C Lupi","year":"2007","unstructured":"Lupi C, Giannini R, Ugolini C et al (2007) Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92(11):4085\u20134090","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"754_CR31","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","volume":"90","author":"M Xing","year":"2005","unstructured":"Xing M, Westra WH, Tufano RP et al (2005) BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90(12):6373\u20136379","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"754_CR32","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1245\/s10434-011-2105-5","volume":"19","author":"BH Lang","year":"2012","unstructured":"Lang BH, Wong KP, Wan KY et al (2012) Significance of metastatic lymph node ratio on stimulated thyroglobulin levels in papillary thyroid carcinoma after prophylactic unilateral central neck dissection. Ann Surg Oncol 19(4):1257\u20131263","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"754_CR33","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hed.23047","volume":"35","author":"J Yip","year":"2013","unstructured":"Yip J, Orlov S, Orlov D et al (2013) Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence. Head Neck 35(4):592\u2013598","journal-title":"Head Neck"},{"issue":"4","key":"754_CR34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1210\/jc.2011-2735","volume":"97","author":"E Fiore","year":"2012","unstructured":"Fiore E, Vitti P (2012) Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease. J Clin Endocrinol Metab 97(4):1134\u20131145","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"754_CR35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2265.2009.03748.x","volume":"73","author":"F Latrofa","year":"2010","unstructured":"Latrofa F, Ricci D, Vitti P et al (2010) Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto\u2019s thyroiditis: evidence against a major effect of age and genetic background on B-cell epitopes. Clin Endocrinol 73(1):110\u2013113","journal-title":"Clin Endocrinol"},{"issue":"4","key":"754_CR36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/ERC-11-0028","volume":"18","author":"E Fiore","year":"2011","unstructured":"Fiore E, Rago T, Latrofa F et al (2011) Hashimoto\u2019s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 18(4):429\u2013437","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"754_CR37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hed.21518","volume":"33","author":"KW Kim","year":"2011","unstructured":"Kim KW, Park YJ, Kim EH et al (2011) Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto\u2019s thyroiditis. Head Neck 33(5):691\u2013695","journal-title":"Head Neck"},{"issue":"3","key":"754_CR38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"JH Lee","year":"2013","unstructured":"Lee JH, Kim Y, Choi JW et al (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol\/Eur Fed Endocr Soc 168(3):343\u2013349","journal-title":"Eur J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"2","key":"754_CR39","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","volume":"84","author":"KC Loh","year":"1999","unstructured":"Loh KC, Greenspan FS, Dong F et al (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84(2):458\u2013463","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"754_CR40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00405-011-1732-6","volume":"269","author":"YH Yoon","year":"2012","unstructured":"Yoon YH, Kim HJ, Lee JW et al (2012) The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 269(3):1013\u20131017","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"754_CR41","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.12194","volume":"79","author":"V Marotta","year":"2013","unstructured":"Marotta V, Guerra A, Zatelli MC et al (2013) BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto\u2019s thyroiditis lymphocytic infiltration is present. Clin Endocrinol 79(5):733\u2013738","journal-title":"Clin Endocrinol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-014-0754-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-014-0754-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-014-0754-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T21:40:44Z","timestamp":1717450844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-014-0754-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1007\/s10147-014-0754-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]}}}